Hemagen Diagnostics, Inc.
HMGN
$0.00
$0.000.00%
| 09/30/2012 | 06/30/2012 | 03/31/2012 | 12/31/2011 | 09/30/2011 | |
|---|---|---|---|---|---|
| Net Income | -23.39% | 45.77% | 33.91% | -30.76% | -486.07% |
| Total Depreciation and Amortization | -8.96% | -8.43% | 0.92% | -2.03% | -6.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.80% | 91.23% | -30.20% | -6.49% | 16.96% |
| Change in Net Operating Assets | -30.05% | 15.63% | -28.68% | -66.56% | 176.35% |
| Cash from Operations | -398.82% | 114.57% | 43.95% | -420.31% | 119.11% |
| Capital Expenditure | 76.77% | -115.28% | 88.87% | -278.36% | -116.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -33.33% | 0.00% |
| Cash from Investing | 76.77% | -115.28% | 75.76% | -183.90% | -20.63% |
| Total Debt Issued | -100.00% | -52.91% | 250.00% | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.00% | -52.91% | 250.00% | -- | -100.00% |
| Foreign Exchange rate Adjustments | 121.10% | -475.74% | 344.93% | 92.87% | -336.10% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -300.98% | -70.00% | 134.93% | -5,362.16% | 104.13% |
